4//SEC Filing
WORLAND STEPHEN T 4
Accession 0001209191-23-055557
CIK 0001828522other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:30 PM ET
Size
5.6 KB
Accession
0001209191-23-055557
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2023-11-15$0.50/sh+5,979$2,973→ 267,204 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
Documents
Issuer
eFFECTOR Therapeutics, Inc.
CIK 0001828522
Entity typeother
Related Parties
1- filerCIK 0001283307
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:30 PM ET
- Size
- 5.6 KB